U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07924618) titled 'Ocular Changes in Patients Using Tirzepatide or Semaglutide' on Oct. 28.
Brief Summary: This prospective observational study aims to evaluate ocular structural and microvascular changes in adults with obesity who are receiving semaglutide or tirzepatide as part of routine clinical care. Participants with and without type 2 diabetes mellitus will be included.
Participants will undergo ophthalmologic examinations at baseline and during follow-up. Changes in optic nerve head parameters, retinal thickness, retinal and choroidal microvascular parameters, and choroidal thickness will be assessed using optical coherence tomography (OCT), ...